查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1882989

生物可吸收冠狀動脈支架市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032）

Bioresorbable Coronary Stents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 165 Pages | 商品交期: 請詢問到貨日

價格

生物可吸收冠狀動脈支架市場成長驅動因子

隨著全球對先進心血管治療需求的不斷增長，全球生物可吸收冠狀動脈支架市場持續穩定擴張。根據最新市場數據，預計2024年全球市場規模將達到3.405億美元，2025年將成長至3.56億美元，到2032年將進一步成長至5.204億美元，預測期內複合年增長率（CAGR）為5.6%。北美地區憑藉其強大的醫療基礎設施和較高的冠狀動脈介入治療數量，在2024年將引領全球市場，佔全球市場佔有率的38.59%。

生物可吸收冠狀動脈支架（也稱為支架）旨在疏通阻塞的動脈後逐漸溶解，從而避免與永久性金屬植入物相關的長期併發症。這些裝置主要由先進聚合物或可生物降解金屬製成，可在體內安全降解前提供暫時的機械支撐。它們能夠恢復血管的自然舒縮功能並降低晚期支架血栓形成的風險，這極大地促進了其廣泛應用。

市場推動因素

市場成長的關鍵推動因素是冠狀動脈疾病 (CAD) 在全球日益普遍。生活方式相關因素，例如飲酒量增加、吸煙、缺乏運動和慢性壓力，都導致了心臟病發病率的急劇上升。例如，美國疾病管制與預防中心 (CDC) 在 2024 年 10 月報告稱，到 2023 年，大約每 20 名 20 歲及以上的美國成年人中就有 1 人患有冠狀動脈疾病 (CAD)，這凸顯了有效治療的緊迫性。隨著全球人口老化，需要微創心臟治療的患者人數持續成長。生物可吸收支架具有多項臨床優勢，包括減少長期併發症和恢復血管功能，因此在已開發國家和發展中國家的醫療保健市場需求不斷增長。

市場限制因子

儘管生物可吸收冠狀動脈支架具有諸多優勢，但它們面臨著來自藥物洗脫支架 (DES) 和金屬支架的激烈競爭，後者擁有成熟的臨床記錄、成本效益和大量的臨床數據。雖然生物可吸收支架的初步結果令人鼓舞，但仍需要更長期的證據來驗證其安全性和有效性。此外，再狹窄和長期血管癒合方面的不確定性仍然是臨床醫生關注的問題，這可能會阻礙其廣泛應用。

市場機會

在醫療基礎設施不斷改善和公眾對心臟病的認識不斷提高的推動下，發展中地區正在湧現出巨大的成長機會。政府主導的舉措，例如印度衛生部於2023年9月啟動的“心臟健康運動”，正在幫助患者了解包括先進支架在內的各種治療方案。世界各地的醫院也正在擴展其心臟病服務。例如，澳洲坎培拉醫院於2024年8月啟用了一座新的重症監護服務大樓，擴大了其介入性心臟病學能力。預計這將推動對生物可吸收支架的需求。

市場挑戰

生物可吸收冠狀動脈支架成本高昂是市場面臨的主要挑戰之一，這是由於其採用了先進的生物材料和複雜的製造過程。截至2025年6月，印度BVS治療的費用在2,500美元至5,000美元之間，這限制了中低收入國家的可及性。此外，企業必須在臨床試驗和監管合規方面投入巨資，從而延緩了產品的上市和推廣。

主要市場趨勢

創新仍是市場成長的核心。製造商正在投資新材料技術、增強藥物洗脫能力和改進支架設計。新一代鎂支架的出現，例如BIOTRONIK公司的Freesolve（已在2024年5月進行的BIOMAG-II試驗中進行了評估），代表著一項重大進步。混合支架設計和生物感測器整合支架正成為未來的解決方案，可提供即時監測和個人化治療。

區域洞察

北美

2024年，北美市場以1.314億美元的規模領先全球市場。冠狀動脈疾病的高發病率和微創手術的日益普及推動了該地區的需求。

歐洲

歐洲佔第二大市場佔有率，這得益於不斷上升的肥胖率和強勁的產品上市。光是在英格蘭，2021年至2022年間，就有25.6%的成年人被報告為肥胖。

亞太地區

2024年，亞太地區排名第三。高吸菸率、壓力大的生活方式和支架植入量的增加是背後的原因。支架治療病例佔比從2019年的13.8%增加到2021年的19.4%。

拉丁美洲、中東和非洲

由於高血壓、糖尿病和生活型態相關疾病的風險因素不斷增加，這些地區的市場規模持續擴大。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家和地區主要疾病發生率（2023/2024）
  • 主要產業趨勢（併購、合作等）
  • 生物可吸收冠狀動脈支架的技術進步
  • 新產品發布
  • 主要疾病的報銷方案流程

第五章：全球生物可吸收冠狀動脈支架市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測 - 依材料分類
    • 金屬
    • 聚合物
  • 市場分析、洞察與預測 - 依應用分類
    • 急性冠狀動脈症候群 (ACS)
    • 慢性冠狀動脈症候群 (CCS)
  • 市場分析、洞察與預測 - 依最終用戶分類
    • 醫院和門診手術中心 (ASC)
    • 專科診所
    • 其他
  • 市場分析、洞察與預測 - 依地區分類
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美生物可吸收冠狀動脈支架市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲生物可吸收冠狀動脈支架市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章亞太地區生物可吸收冠狀動脈支架市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲生物可吸收冠狀動脈支架市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東和非洲生物可吸收冠狀動脈支架市場分析、洞察與預測2019-2032

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析 (2024)
  • 公司簡介
    • 波士頓科學公司 (Boston Scientific Corporation)
    • 泰爾茂株式會社 (Terumo Corporation)
    • 瑞利思醫療器材有限公司 (Relisys Medical Devices Limited)
    • 微創醫療器材股份有限公司 (MicroPort Scientific Corporation)
    • 樂普醫療 (Lepu Medical)
    • 艾力達醫療 (Elixir Medical)
    • 中國醫藥集團有限公司 (SINOMED)
    • 瑞瓦醫療股份有限公司 (Reva Medical, LLC.)
    • ELLA-CS, s.r.o.
Product Code: FBI113733

Growth Factors of bioresorbable coronary stents Market

The global bioresorbable coronary stents market is witnessing steady expansion as the demand for advanced cardiovascular treatments increases worldwide. According to the latest market data, the global market size reached USD 340.5 million in 2024, is projected to grow to USD 356.0 million in 2025, and is expected to rise significantly to USD 520.4 million by 2032, reflecting a CAGR of 5.6% during the forecast period. North America dominated the global market in 2024, accounting for 38.59% of the total share owing to its strong healthcare infrastructure and high coronary intervention volume.

Bioresorbable coronary stents-also called scaffolds-are designed to gradually dissolve after opening blocked arteries, eliminating the long-term complications associated with permanent metallic implants. Made primarily from advanced polymers or biodegradable metals, these devices provide temporary mechanical support before safely degrading inside the body. Their ability to restore natural vasomotion and reduce the risk of late stent thrombosis has contributed significantly to rising adoption.

Market Drivers

The key driver of market growth is the increasing global prevalence of coronary artery disease (CAD). Lifestyle-related factors such as rising alcohol consumption, smoking, physical inactivity, and chronic stress are causing a surge in cardiac cases. For example, the CDC reported in October 2024 that nearly 1 in 20 U.S. adults aged 20+ suffered from CAD in 2023, highlighting the critical need for effective treatments. As aging populations expand worldwide, the number of patients requiring minimally invasive cardiology procedures continues to rise. Bioresorbable stents offer several clinical advantages, such as reduced long-term complications and restored vascular function, strengthening their demand in both developed and developing healthcare markets.

Market Restraints

Despite their benefits, bioresorbable coronary stents face strong competition from drug-eluting stents (DES) and metallic stents, which are well-established, cost-effective, and backed by extensive clinical data. While early results for bioresorbable devices are promising, more long-term evidence is needed to validate their safety and performance. Additionally, uncertainties regarding restenosis and long-term vessel healing remain concerns among clinicians, potentially slowing widespread adoption.

Market Opportunities

Significant growth opportunities are emerging in developing regions, driven by improving healthcare infrastructure and rising public awareness of cardiac diseases. Government-led initiatives, such as the Indian Ministry of Health's heart health campaign in September 2023, are helping educate patients about treatment options, including advanced stenting procedures. Hospitals worldwide are also expanding cardiology services. For instance, Canberra Hospital in Australia launched a new critical services building in August 2024 to expand cardiovascular intervention capabilities, supporting greater demand for bioresorbable stents.

Market Challenges

A major challenge in the market is the high cost of bioresorbable coronary stents, driven by advanced biomaterials and complex manufacturing processes. As of June 2025, BVS treatment in India ranged from USD 2,500-5,000, limiting affordability in low- and middle-income countries. Furthermore, companies must invest heavily in clinical trials and regulatory compliance, slowing product availability and market penetration.

Key Market Trends

Innovation remains central to market growth. Manufacturers are investing in new material technologies, enhanced drug-eluting capabilities, and improved stent designs. The launch of next-generation magnesium scaffolds, such as BIOTRONIK's Freesolve evaluated in the BIOMAG-II trial in May 2024, highlights significant progress. Hybrid stent designs and biosensor-integrated stents are emerging as future solutions, offering real-time monitoring and personalized treatment.

Regional Insights

North America

North America led the market in 2024 with USD 131.4 million in value. Strong CAD prevalence and increased adoption of minimally invasive procedures are driving regional demand.

Europe

Europe held the second-largest share, supported by rising obesity rates and strong product introductions. In England alone, 25.6% of adults were reported obese between 2021-2022.

Asia Pacific

Asia Pacific ranked third in 2024, driven by high smoking rates, stressful lifestyles, and increased stent placements. Stent treatment cases increased from 13.8% in 2019 to 19.4% in 2021.

Latin America & Middle East & Africa

These regions continue to grow due to rising hypertension, diabetes, and lifestyle-related risks.

Conclusion

With the market increasing from USD 340.5 million in 2024 to USD 356.0 million in 2025, and projected to reach USD 520.4 million by 2032, the bioresorbable coronary stents market is positioned for sustained growth. Advances in biomaterials, rising cardiovascular cases, and global expansion of cardiology services will continue to shape the industry's trajectory.

Segmentation By Application

  • Acute Coronary Syndrome (ACS)
  • Chronic Coronary Syndrome (CCS)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Geography

  • North America (By Material, Application, End-user, and Country/Sub-region)
    • U.S.
    • Canada
  • Europe (By Material, Application, End-user, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Material, Application, End-user, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Material, Application, End-user, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Material, Application, End-user, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Incidence of Key Diseases, By Key Countries/Regions, 2023/2024
  • 4.2. Key Industry Developments - (Mergers, Acquisition & Partnerships, etc.)
  • 4.3. Technological Advancements in the Bioresorbable Coronary Stents
  • 4.4. New Product Launches
  • 4.5. Reimbursement Scenario for Key Procedures

5. Global Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Material
    • 5.1.1. Metal
    • 5.1.2. Polymer
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Acute Coronary Syndrome (ACS)
    • 5.2.2. Chronic Coronary Syndrome (CCS)
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Material
    • 6.1.1. Metal
    • 6.1.2. Polymer
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Acute Coronary Syndrome (ACS)
    • 6.2.2. Chronic Coronary Syndrome (CCS)
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Material
    • 7.1.1. Metal
    • 7.1.2. Polymer
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Acute Coronary Syndrome (ACS)
    • 7.2.2. Chronic Coronary Syndrome (CCS)
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Material
    • 8.1.1. Metal
    • 8.1.2. Polymer
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Acute Coronary Syndrome (ACS)
    • 8.2.2. Chronic Coronary Syndrome (CCS)
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Material
    • 9.1.1. Metal
    • 9.1.2. Polymer
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Acute Coronary Syndrome (ACS)
    • 9.2.2. Chronic Coronary Syndrome (CCS)
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bioresorbable Coronary Stents Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Material
    • 10.1.1. Metal
    • 10.1.2. Polymer
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Acute Coronary Syndrome (ACS)
    • 10.2.2. Chronic Coronary Syndrome (CCS)
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Terumo Corporation
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Relisys Medical Devices Limited
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. MicroPort Scientific Corporation
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Lepu Medical
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Elixir Medical
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. SINOMED
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Reva Medical, LLC.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. ELLA - CS, s.r.o
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 2: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 3: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 4: Global Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Region, 2019-2032
  • Table 5: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 6: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 7: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 8: North America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country, 2019-2032
  • Table 9: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 10: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 11: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 12: Europe Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 14: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 15: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 16: Asia Pacific Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 17: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 18: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 19: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 20: Latin America Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Material, 2019-2032
  • Table 22: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by Application, 2019-2032
  • Table 23: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, by End-user, 2019-2032
  • Table 24: Middle East & Africa Bioresorbable Coronary Stents Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Bioresorbable Coronary Stents Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032
  • Figure 2: Global Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024 & 2032
  • Figure 3: Global Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024 & 2032
  • Figure 4: Global Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024 & 2032
  • Figure 5: Global Bioresorbable Coronary Stents Market Value (USD million), by Region, 2024 & 2032
  • Figure 6: North America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 7: North America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 8: North America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 9: North America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 10: North America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 11: North America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 12: North America Bioresorbable Coronary Stents Market Value (USD million), By Country, 2024 & 2032
  • Figure 13: North America Bioresorbable Coronary Stents Market Value Share (%), By Country, 2024
  • Figure 14: Europe Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 15: Europe Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 16: Europe Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 17: Europe Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 18: Europe Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 19: Europe Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Bioresorbable Coronary Stents Market Value (USD million), By Country/Sub-region, 2024 & 2032
  • Figure 21: Europe Bioresorbable Coronary Stents Market Value Share (%), By Country/Sub-region, 2024
  • Figure 22: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 23: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 24: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 25: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 27: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 31: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 32: Latin America Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 33: Latin America Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 35: Latin America Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Material, 2024 & 2032
  • Figure 39: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Material, 2024
  • Figure 40: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by Application, 2024 & 2032
  • Figure 41: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), by End-user, 2024 & 2032
  • Figure 43: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Bioresorbable Coronary Stents Market Value (USD million), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Bioresorbable Coronary Stents Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Bioresorbable Coronary Stents Market Share (%), By Company, 2024